Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

TY - JOUR

T1 - Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia

AU - Afzal, Amber

AU - Fiala, Mark A.

AU - Jacoby, Meagan A.

AU - Walter, Matthew J.

N1 - Funding Information: Acknowledgments: This work was supported by grants from the Siteman Cancer Center, the Foundation for Barnes-Jewish Hospital Cancer Frontier Fund (5109), the Lottie Caroline Hardy Trust, the Edward P. Evans Center for Myelodysplastic Syndromes at Washington University, and the Edward P. Evans Foundation (to M.J.W.).

PY - 2023/8/8

Y1 - 2023/8/8

UR - https://www.scopus.com/pages/publications/85170100350

U2 - 10.1182/bloodadvances.2023009818

DO - 10.1182/bloodadvances.2023009818

M3 - Letter

C2 - 37042968

AN - SCOPUS:85170100350

SN - 2473-9529

VL - 7

SP - 3838

EP - 3841

JO - Blood Advances

JF - Blood Advances

IS - 15

ER -